Ketamine for Sedation in the Intensive Care Unit

New Orleans, LA US
January 9, 2020

Sedation depresses the awareness of the ICU patients to reduce their response to invasive procedures, lessens patient-ventilator dyssynchrony, prevents agitation, and decreases stress and oxygen consumption. Currently, at OMC, ketamine is mainly being used for refractory status epilepticus and pain control (or hyperalgesia) with available dosing guidelines and protocol. No standard dosing is available for other indications such as sedation in the ICU. It is not one of sedative options in the sedation order set. If the medical team needs a sedative alternative for those patients who cannot tolerate fentanyl, propofol, dexmedetomidine, or midazolam, it is imperative for the team and pharmacists to be aware of the benefits of adding ketamine in certain patient populations as well as dosing, administration, and monitoring of ketamine. This activity will provide pharmacists and pharmacy technicians with sedation protocols, ketamine dosing comparisons for different indications, ketamine administration standards, suggested dosing, and target population to use ketamine for sedation in the ICU.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Describe the indications for sedation and how to appropriately monitor sedative therapies in the ICU
  2. Analyze the recent trials evaluating the use of ketamine for sedation in the ICU
  3. Design a therapeutic plan utilizing ketamine for ICU sedation

Pharmacy technician learning objectives

  1. Identify different agents used for sedation in the ICU
  2. Recognize different routes of administration of ketamine used for various indications and settings
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance
Course opens: 
01/09/2020
Course expires: 
02/23/2020
Event starts: 
01/09/2020 - 12:00pm
Event ends: 
01/09/2020 - 1:00pm
Cost:
$0.00
Ochsner Medical Center
1514 Jefferson Hwy.
New Orleans, LA 70121
United States

Relevant financial relationships: Planning committee members and the presenter have nothing to disclose

The presenter will discuss off-label use of drugs

Planning committee members
Katherine Jennings, PharmD, BCCCP
Pharmacist
Ochsner Medical Center
 
Kinsey Kowalski, PharmD, BCCCP
Pharmacist
Ochsner Medical Center
 
Course reviewer
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient
 
Presenter
Anh Nguyen, PharmD
PGY1 Pharmacy Resident
Ochsner Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-020-L04-P
Universal Activity Number: JA0006103-9999-20-020-L04-T
 
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.